Forecast of Global Liquid Biopsy Products Market 2023

Global Liquid Biopsy Products market will register a 27.8% CAGR in terms of revenue, reach US$ 2710 million by 2023, from US$ 620 million in 2017. Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.